Table 1.
Characteristic | n |
Male | 63 |
Age (yrs), median (min-max) | 9 (0–18) |
BCG vaccinated* | 68 |
BCG non-vaccinated | 6 |
BCG vaccination status unknown | 25 |
Born outside Finland or at least one of the parents is from a country with endemic TB: | 57 |
➢ Somalia (several families) | 25 |
➢ Vietnam | 6 |
➢ Peru (1 family) | 4 |
➢ Russia | 4 |
➢ Kosovo | 2 |
➢ Nigeria | 2 |
➢ Afghanistan, Angola, Azerbadzan, Burma Burundi, Estonia, India, Congo, Sudan, Thailand, Turkey, Uganda | 12 (one each) |
➢ Siblings who live in Russia | 2 |
HIV infection | 2 |
TST test performed | 87 |
TST not performed | 8 |
Data missing | 4 |
Culture or/and Nucleic acid amplification (NAA) method performed | 6 |
➢ acid fast staining positive | 2/6 (also culture pos) |
➢ culture positive (M. tuberculosis) | 4/6 |
➢ NAA positive | 2/6 (also culture pos) |
Radiological examination performed | 95 |
Radiological findings | |
➢ normal | 81/95 (85%) |
➢ pulmonary TB | 4 |
➢ enlargement of the hilus zone (Hodgkin lymphoma, TB lymphadenitis, one mild in LTBI, one mild in salmonelosis) | 4 (one each) |
➢ interstitial changes (vasculitis) | 1 |
➢ pleural effusion (pleuritis and chylothorax) | 2 |
➢ pneumonia | 2 |
➢ bronchoectasia | 1 |
Indications for IGRA-tests | |
➢ exposure to TB | 62 |
➢ clinical signs compatible with TB | 37 |
* All children born in Finland before September 2006 were supposed to be BCG vaccinated even if this was not mentioned in the record.